<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01436903</url>
  </required_header>
  <id_info>
    <org_study_id>743/2010</org_study_id>
    <nct_id>NCT01436903</nct_id>
  </id_info>
  <brief_title>Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length</brief_title>
  <official_title>Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length, a Questionnaire Investigation on 290 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      CavatermTM is a second-generation thermal balloon ablation device in the management of
      menorrhagia. The purpose of this study is to investigate the success (questionnaire) of
      CavatermTM dependent on uterus probe length, especially corpus probe length, which is
      measured during surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postsurgical change in bleeding patterns dependent on cavum probe length.</measure>
    <time_frame>Corpus probe length will be measured during surgery, a questionnaire will be sent in September 2010, at least after one postsurgical year.</time_frame>
    <description>Success is defined as a-, hypo- or eumenorrhoea, regular cycle, reduction of dysmenorrhoea.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postsurgical change in patient satisfaction dependent on cavum probe length.</measure>
    <time_frame>Corpus probe length will be measured during surgery, a questionnaire will be sent in September 2010, at least after one postsurgical year.</time_frame>
    <description>The questionnaire will ask for satisfaction and recommendation to the best friend.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postsurgical change in dyspareunia</measure>
    <time_frame>A questionnaire will be sent in September 2010, at least after one postsurgical year.</time_frame>
    <description>The questionnaire will ask for pre- and postsurgical dyspareunia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postsurgical change in Premenstrual Syndrome</measure>
    <time_frame>A questionnaire will be sent in September 2010, at least after one postsurgical year.</time_frame>
    <description>The questionnaire will ask for pre- and postsurgical Premestrual Syndrome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevention of further gynaecological therapies</measure>
    <time_frame>A questionnaire will be sent in September 2010, at least after one postsurgical year.</time_frame>
    <description>The questionnaire will ask for postsurgical hysterectomy and further medications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of quality of life</measure>
    <time_frame>A questionnaire will be sent in September 2010, at least after one postsurgical year.</time_frame>
    <description>The questionnaire will ask for postsurgical quality of life.</description>
  </secondary_outcome>
  <enrollment type="Actual">290</enrollment>
  <condition>Menorrhagia</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Thermal Balloon Endometrial Ablation</intervention_name>
    <description>Thermal Balloon Endometrial Ablation for 10 minutes after curettage</description>
    <other_name>CavatermTM</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CavatermTM operation because of menorrhagia

          -  timeframe: January 2006 till August 2009

          -  older than 29 years and younger than 56 years

        Exclusion Criteria:

          -  pregnancy

          -  fragmentary filled questionnaire

          -  more than 1 CavatermTM operation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beda W. Hartmann, Univ.-Doz.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Landesklinikum Thermenregion Neunkirchen</name>
      <address>
        <city>Neunkirchen</city>
        <state>Lower Austria</state>
        <zip>2620</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2011</study_first_submitted>
  <study_first_submitted_qc>September 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2011</study_first_posted>
  <last_update_submitted>March 7, 2013</last_update_submitted>
  <last_update_submitted_qc>March 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Beda Hartmann</investigator_full_name>
    <investigator_title>Univ.-Doz. Dr. Mag.</investigator_title>
  </responsible_party>
  <keyword>menorrhagia</keyword>
  <keyword>dysfunctional uterine bleeding</keyword>
  <keyword>endometrial ablation</keyword>
  <keyword>cavatermTM</keyword>
  <keyword>probe</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menorrhagia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

